How does MOH/medical practitioners/Hospitals assess and treat Covid vaccine reactions
Tracy Livingston made this Official Information request to Ministry of Health
Ministry of Health did not have the information requested.
From: Tracy Livingston
Dear Ministry of Health,
1) What diagnostic criteria, i.e. blood tests etc is in place to assess COVID vaccine adverse events in E.D., and medical centres?
2) What tests are applicable for testing for COVID vaccine adverse events?
3) what treatments have hospital staff found effective, and are being used, in NZ for recovering from a covid vaccine adverse event?
4) What pathological effects have been found on autopsy following a covid vaccine related death?
and for ACC
5) How many ACC claim forms have been received to date for covid vaccine adverse events, and what were the adverse events ?
Yours faithfully,
Tracy Livingston
From: OIA Requests
Kia ora
Thank you for your request for official information received 27 May 2021
for:
" 1) What diagnostic criteria, i.e. blood tests etc is in place to assess
COVID vaccine adverse events in E.D., and medical centres?
2) What tests are applicable for testing for COVID vaccine adverse events?
3) what treatments have hospital staff found effective, and are being
used, in NZ for recovering from a covid vaccine adverse event?
4) What pathological effects have been found on autopsy following a covid
vaccine related death?
and for ACC
5) How many ACC claim forms have been received to date for covid vaccine
adverse events, and what were the adverse events ?”
The Ministry's reference number for your request is: H202106535.
As required under the Official Information Act 1982 we will endeavour to
respond to your request no later than 17 June 2021, being 20 working days
after the day your request was received.
If we are unable to respond to your request within this time frame, we
will notify you of an extension of that time frame.
If you have any queries related to this request, please do not hesitate to
get in touch.
Ngâ mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [1][email address]
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. mailto:[email address]
hide quoted sections
From: OIA Requests
Kia ora,
The below acknowledgement email contains a error with regards to the date
a response is due.
As required under the Official Information Act 1982 we will endeavour to
respond to your request no later than 25 June 2021, being 20 working days
after the day your request was received. Not 17 June 2021 as is written
below.
My apologies for the error.
Ngā mihi,
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [1][email address]
From: Vince Neaves On Behalf Of OIA Requests
Sent: Monday, 31 May 2021 2:46 pm
To: [FOI #15591 email]
Cc: OIA Requests <[email address]>
Subject: Acknowledgement of your request for official information (ref:
H202106535)
Kia ora
Thank you for your request for official information received 27 May 2021
for:
" 1) What diagnostic criteria, i.e. blood tests etc is in place to assess
COVID vaccine adverse events in E.D., and medical centres?
2) What tests are applicable for testing for COVID vaccine adverse events?
3) what treatments have hospital staff found effective, and are being
used, in NZ for recovering from a covid vaccine adverse event?
4) What pathological effects have been found on autopsy following a covid
vaccine related death?
and for ACC
5) How many ACC claim forms have been received to date for covid vaccine
adverse events, and what were the adverse events ?”
The Ministry's reference number for your request is: H202106535.
As required under the Official Information Act 1982 we will endeavour to
respond to your request no later than 17 June 2021, being 20 working days
after the day your request was received.
If we are unable to respond to your request within this time frame, we
will notify you of an extension of that time frame.
If you have any queries related to this request, please do not hesitate to
get in touch.
Ngā mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [2][email address]
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. mailto:[email address]
2. mailto:[email address]
hide quoted sections
Ministry of Health
Kia ora
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [email address]
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
hide quoted sections
Ministry of Health
Kia ora
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [email address]
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
hide quoted sections
From: Government Services
Kia ora Tracy
Please find attached our response to your official information request
dated 03 June 2021. If you have any questions about the response you can
contact us at this [1]address, for all other matters please use our
contact form at: [2]https://www.acc.co.nz/contact/ alternatively give us a
call on 0800 101 996.
If you are having trouble viewing the PDF, please ensure you have the
latest version of Adobe Acrobat Reader. To download this freeware please
click [3]here.
Ngâ mihi
Sasha Wood, Manager OIA Services, ACC
ACC cares about the environment – please don’t print this
email
unless it is really necessary. Thank you.
References
Visible links
1. mailto:[email address]
2. https://www.acc.co.nz/contact/
3. https://get.adobe.com/nz/reader/
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
victor left an annotation ()
https://www.medsafe.govt.nz/COVID-19/mon...
Published: 27 November 2020
Revised: 10 February 2021
How will Medsafe monitor COVID-19 vaccine safety?
Medsafe has not yet finalised all of the methods that we will use to monitor COVID-19 vaccine safety.
- MOH deferring to ACC for advice is a powerful indication MOH MEDSAFE are unable to finalize the safety monitoring processes because there is little to no published advice on anything other than local reactogenicity.
Systemic adverse events as observed in the MEDSAFE summaries are being grossly underreported. Medical staff or amateur vaccinators are untrained in adverse event clinical presentation outside those which are listed on MOH portal.
As such medical staff have no indications what new technology adverse events could present as.
CARM system and processes has a historical baseline of <2.9% adverse event reporting or a 34.5 fold rate of under reporting going back more than 20.years.
Stats are from official gov sources including CARMS own portal and document produced by CARM Clinical Risk Management Team.
https://bpac.org.nz/bpj/2014/april/react...
'For example, analysis of the data stored in the Patient Management Systems of 30 general practices found that of the 725 entries in the medical warnings files that recorded an adverse reaction or allergy to at least one medicine, only 21 were reported to CARM.'
Link to this